CAS 23103-35-7
:Hexasodium de Trispyrophosphate de Myo-Inositol
- ITTP Hexasodium Salt
- Itpp Sodium Salt
myo-Inositol Trispyrophosphate Hexasodium Salt
CAS :Formule :C6H12Na6O24P6Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :791.9263myo-Inositol trispyrophosphate hexasodium salt
CAS :Formule :C6H6Na6O21P6Degré de pureté :≥ 95%Couleur et forme :White to off-white powderMasse moléculaire :737.88myo-Inositol Trispyrophosphate Hexasodium Salt
CAS :Formule :C6H6O21P6·6NaMasse moléculaire :599.94 6 22.99myo-Inositol-d6 Trispyrophosphate Hexasodium Salt
CAS :Produit contrôléApplications Labelled myo-Inositol Trispyrophosphate hexasodium (I666020). A novel membrane-permeant allosteric effector of hemoglobin (Hb), enhances the regulated oxygen release capacity of red blood cells, thus counteracting the effects of hypoxia in diseases such as cancer and cardiovascular ailments.
References Duarte,C.D. et al.: Chembiochem., 11, 2543 (2010); Biolo, A. et al.: Proc. Nat. Acad. Sci. U.S.A., 106, 1926 (2009);Formule :C6D6Na6O21P6Couleur et forme :White To Light BeigeMasse moléculaire :743.92myo-Inositol Trispyrophosphate Hexasodium Salt
CAS :Produit contrôléStability Hygroscopic
Applications A novel membrane-permeant allosteric effector of hemoglobin (Hb), enhances the regulated oxygen release capacity of red blood cells, thus counteracting the effects of hypoxia in diseases such as cancer and cardiovascular ailments.
References Duarte,C.D. et al.: Chembiochem., 11, 2543 (2010); Biolo, A. et al.: Proc. Nat. Acad. Sci. U.S.A., 106, 1926 (2009);Formule :C6H6O21P6NaCouleur et forme :NeatMasse moléculaire :737.88myo-Inositol trispyrophosphate hexasodium salt
CAS :Myo-Inositol trispyrophosphate (ITPP) hexasodium salt is a drug with anti-cancer properties. It is an allosteric effector that interact with hemoglobin, releasing oxygen into the target tissues to avoid hypoxia. Several studies has shown an increase on the affinity of hemoglobin to oxygen when using ITPP, fact that demonstrated it can be a good strategy for the treatment of several cardiovascular diseases.Formule :C6H6Na6O21P6Degré de pureté :Min. 95%Couleur et forme :White Off-White PowderMasse moléculaire :737.88 g/mol




